| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.52B | $ 1.30B | $ 1.02B | $ 977.89M | $ 942.26M |
| Gross Profit | $ 511.71M | $ 399.94M | $ 313.09M | $ 298.24M | $ 285.40M |
| Operating Income | $ 198.44M | $ 110.47M | $ 53.31M | $ 71.85M | $ 78.99M |
| EBITDA | $ 236.46M | $ 146.85M | $ 69.06M | $ 106.03M | $ 117.13M |
| Net Income | $ 99.72M | $ 48.26M | $ 2.42M | $ 32.61M | $ 49.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 81.99M | $ 77.04M | $ 114.61M | $ 81.28M | $ 91.25M |
| Total Assets | $ 1.50B | $ 1.36B | $ 982.18M | $ 971.40M | $ 931.70M |
| Total Debt | $ 591.77M | $ 761.55M | $ 525.46M | $ 509.97M | $ 470.48M |
| Net Debt | $ 530.35M | $ 693.51M | $ 454.85M | $ 468.69M | $ 396.24M |
| Total Liabilities | $ 1.12B | $ 1.08B | $ 725.54M | $ 688.89M | $ 669.26M |
| Stockholders' Equity | $ 385.48M | $ 285.68M | $ 256.64M | $ 282.51M | $ 262.44M |
| Cash Flow | |||||
| Free Cash Flow | $ 9.87M | $ 41.83M | $ 46.36M | $ -38.48M | $ -5.39M |
| Operating Cash Flow | $ 68.95M | $ 80.12M | $ 87.59M | $ 13.31M | $ 31.65M |
| Investing Cash Flow | $ -71.45M | $ -288.69M | $ -48.19M | $ -74.02M | $ -22.58M |
| Financing Cash Flow | $ -6.56M | $ 207.13M | $ -6.77M | $ 26.99M | $ 16.34M |
Phibro Animal Health (DE:PB8)
FRANKFURT:PB8
